Welcome to LookChem.com Sign In | Join Free
Home > Products > Daxas

Daxas

Some introduction of Daxas, Daxas 500microgram tablets, COPD and Roflumilast Preparation.
  • Product Details
  • Company Profile

    1. The overview of Daxas
    Roflumilast(Daxas or BYK 20869)
     is a selective, long-acting the enzyme PDE-4 inhibitor with an IC50 of 0.8 nM in HANGZHOU HOLYPHARM BIOTECH CO.,LTDDaxas is a drug which acts as a selective, long-acting inhibitor of the enzyme PDE-4. It has antiinflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs. In March 2011, Daliresp gained FDA approval in the US for reducing COPD exacerbations.

    2. What is COPD?
    COPD
    is an under-diagnosed progressive lung disease that may lead to death. Worldwide, COPD kills four people every minute and the World Health Organization (WHO) predicts that it will be the third leading cause of death by 2030. WHO estimates that 80 million people have moderate to severe COPD.

    3. The Preparation of Roflumilast:
    Roflumilast Preparation
    is as follows:



    4. Daxas 500microgram tablets
    Daxas 500microgram tablets
     is an anti-inflammatory medicine and is used in the treatment of chronic obstructive airways disease. It works by blocking the action of some of the chemicals that cause inflammation in the lungs. It is used in combination with bronchodilators. When to take this medicine, please talk to your prescriber or pharmacist and take it correctly.

Verified Supplier

Escrow ServiceMore
Secure Your Orders With escrow More Transparency,Less Uncertainty

Send a message direct to supplier(s)

*From:
Enter email or Member ID
To:
HANGZHOU HOLYPHARM BIOTECH CO.,LTD
Subject:
*Message:

-Enter between 20 to 2000 letters.English only. Word count:0 letter(s).
-We suggest you include in your inquiry a brief introduction to your company as well as your product requirements
 

Related products